spacer
home > pmps > winter 2002 > the financial and operational benefits of e-learning in regulatory compliance
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Financial and Operational Benefits of e-Learning in Regulatory Compliance

We believe that e-learning will increasingly be employed by pharmaceutical organisations to achieve and maintain compliance training as mandated by the regulatory authorities. e-Learning not only enhances compliance initiatives but also delivers the benefits of improved operational efficiency and higher profitability. Given the global nature of today's pharmaceutical operations, as well as an increased regulatory burden, e-learning has found a niche in the pharmaceutical manufacturing process, and ties in well with new FDA technology initiatives.

It has been well documented that e-learning cuts down the learning curve and delivers significant cost savings associated with traditional instructor led training (ILT). Furthermore, its interactive nature improves employee (student) material retention rates, and offers companies with customised solutions to their training needs. Since e-learning and computer-based training (CBT) integrates and complements traditional classroom-based training programmes, companies could achieve higher employee productivity by adopting a blended approach to learning.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Chakri Lokapriya, Managing Consultant - Compliance Solutions, and Tony Kypreos, Chief Commercial Officer, at Maersk Data UK
Chakri Lokapriya is Managing Consultant - Compliance Solutions at Maersk Data UK, a company which provides tailored audits and pilots in the areas of validation process, electronic records and signatures and computer validation. Prior to this, he was an Equity Analyst covering health care companies at JP Morgan and UBS Warburg. Chakri is a Director of Prinvex.

Tony Kypreos is Chief Commercial Officer at Maersk Data UK. Prior to this, he was European Vice-President of Strategic Services at Omnicom Group, and for nine years he held senior marketing and sales roles for Nestlй and Diageo.


spacer
Chakri Lokapriya
spacer
spacer
spacer
Tony Kypreos
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

High Throughput Analytics Herald a Paradigm Shift in the Development of Biopharmaceuticals

Heilbronn/Dortmund August 2019: Biopharmaceuticals have revolutionized therapies of various diseases. In particular with regard to chronical and/or severe clinical conditions like multiple sclerosis, rheumatoid arthritis or cancer they are considered the future of treatment. Also economically biological drugs are on their way up: The global biopharmaceuticals market is anticipated to reach about 400 billion USD by 2025. Which strategic alignment will help best to fill a successful pipeline?
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement